Loading...

Albert Labs International Corp.

ABRT.CN•CNQ
Healthcare
Biotechnology
CA$0.005
CA$0.00(0.00%)

Albert Labs International Corp. (ABRT.CN) Company Profile & Overview

Explore Albert Labs International Corp.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Albert Labs International Corp. (ABRT.CN) Company Profile & Overview

Albert Labs International Corp. operates as a clinical research and drug development company. The company focuses on treating patients with urgent and unmet needs, including critical mental health indications. It develops psilocybin-assisted therapies to improve mental health conditions, including anxiety, depression, and oncology-related distress. The company is based in Burnaby, Canada.

SectorHealthcare
IndustryBiotechnology
CEONavchand Jagpal

Contact Information

https://albertlabs.com
778-819-0740
6996 Merritt Avenue, Burnaby, BC, V5J 4R6

Company Facts

IPO DateFeb 1, 2023
CountryCA

Frequently Asked Questions

;